healthcare technology

Industry observers like myself have often painted the competitive mHealth landscape with a brush that wages computer manufacturer Dell and software behemoth Microsoft versus Apple--the reigning mobile healthcare champion. However, the real battle for the heart, mind and soul of the still-emerging mHealth market places Apple and search engine giant Google squarely in the commercial trenches.

Apple's iPhone and iPad have set the standard for other mobile devices in healthcare. Doctors, in particular, simply love their iPhones and iPads. But, now, the mHealth war between Apple and Google appears to be entering a new battlefield, namely wearable devices. 

At the center of Apple's efforts in this area is its long-awaited iWatch, a wristwatch-like computing device with smartphone/tablet and health/activity tracking capabilities. Reportedly, iWatch includes a pedometer for counting steps and sensors for monitoring health-related data such as heart rate.

Apple is growing its team of medical sensor specialists by hiring some of the world's premiere experts in mobile medical technologies. Presumably, this expertise will be heavily leveraged by Apple in their development of the iWatch or some other device.    

Simultaneously, Google has been working on its much-heralded Google Glass, high-tech glasses which contain a heads-up display, camera and a microphone, and can ostensibly support mobile health apps directly on the device. Google Glass, developed by the company's secretive Google X lab, has strong potential for healthcare, particularly in the ER where physicians could use the glasses to scroll through lab and radiology results and in the OR providing surgeons with hands-free access to critical clinical information.

In addition, earlier this month, Google unveiled its contact lenses, which use a tiny sensor and wireless transmitter, to monitor and measure glucose levels in tears, potentially replacing the self-administered blood tests from finger pricks that diabetics must endure on a daily basis. Not surprisingly, Google employees recently met with U.S. Food and Drug Administration officials at FDA headquarters who regulate eye devices. 

Who will be first to market with these wearable devices--Apple or Google--remains to be seen. What is certain, however, is that the two technology leaders with track records for building strong brands will no doubt dazzle the marketplace with innovative, leading-edge products that put sensor-based devices in the hands of consumers and medical professionals. That kind of competition in mHealth can only serve to benefit us all as this nascent industry moves forward

More at  http://www.fiercemobilehealthcare.com/story/apple-vs-google-mhealth-face/2014-01-27

Cybersecurity attacks on Healthcare and Public Health (HPH) critical infrastructure, such as healthcare delivery organizations (HDOs), are occurring with greater frequency.  Disruptions in clinical care operations can put patients at risk.

Securing critical infrastucture is a shared responsibility across many stakeholders, and with respect to medical
devices the primary stakeholders are FDA, Medical Device Manufacturers (MDMs), and HDOs.

 

A common preparedness and response challenge FDA heard from its stakeholders in the aftermath of the aforementioned attacks is that

• HDOs did not know with whom to communicate (e.g. MDM-HDO interactions);
• what actions they might consider taking;
• and what resources were available to aid in their response.

 

Without timely, accurate information and incorporation of medical device cybersecurity into their organizational emergency response plans, it was difficult for HDOs to assess and mitigate the impact of these attacks on their medical devices.

 

To address this unmet need, the MITRE team (with the support of FDA), engaged with a broad distribution of stakeholder groups to understand the gaps, challenges, and resources for HDOs participating in medical device cybersecurity preparedness and response activities.

 

Their efforts resulted in the creation of this playbook that may serve as a resource for HDOs.

 

The playbook provides a stakeholder-derived, open source, and customizable framework that HDOs may choose to leverage as a part of their emergency response plans in order to ultimately limit disruptions in continuity of clinical care as well as the potential for direct patient harm stemming from medical device cyber security incidents.

 

The link to the PDF of the first version of the playbook -> https://www.mitre.org/sites/default/files/publications/pr-18-1550-Medical-Device-Cybersecurity-Playbook.pdf

 

Researchers and collaborators of the Soh lab at UC Santa Barbara have developed an implantable device to monitor real time concentrations of medications in the blood. The device, called the MEDIC (Microfluid Electrochemical Detector for In Vivo Concentrations), aims to address an increasingly identified problem in medicine – that people metabolize and respond to the same medication at the same dose in very different ways.

Batteries made from pigments found in cuttlefish ink may lead to edible, dissolvable power sources for new kinds of medical devices. Researchers led by Carnegie Mellon University materials scientist Christopher Bettinger demonstrated the new battery. “Instead of lithium and toxic electrolytes that work really well but aren’t biocompatible, we chose simple materials of biological origin,” Bettinger says.